Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade
29 December 2025
1 min read

Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade

NEW YORK, December 29, 2025, 13:26 ET — Regular session

  • Linde shares rose about 0.3% as broader U.S. equities slipped.
  • Year-end trading volumes stayed light ahead of the New Year’s holiday market closure.
  • Investors are watching Fed minutes, jobless claims and Linde’s next earnings update.

Linde shares rose 0.3% to $426.07 in early afternoon trading on Monday, after moving between $423.65 and $427.29 in the session.

The industrial gases maker held up even as U.S. stocks dipped from record highs in thin, holiday-shortened trading — a setup that can exaggerate moves in individual names.

“It’s a very light trading week ahead; volume is low,” said Sam Stovall, chief investment strategist at CFRA Research in New York. He pointed to tax-loss harvesting — selling losing positions to offset capital-gains taxes — as one factor that can distort late-year flows. Reuters

The SPDR S&P 500 ETF Trust was down about 0.5%, with heavyweight technology and AI-linked shares leading the broader pullback, Reuters reported. Investors are also looking to minutes from the Federal Reserve’s prior meeting and weekly jobless claims later this week, with U.S. markets shut on Thursday for New Year’s Day. Reuters

Linde, the world’s largest industrial gases company, supplies oxygen, nitrogen and hydrogen to customers ranging from factories to hospitals, leaving the stock sensitive to shifts in industrial demand but often steadied by long-term supply contracts. Reuters

Peer Air Products & Chemicals edged higher as well, while the broader market stayed in the red.

The company’s investor website lists its most recent corporate update as its third-quarter results released on Oct. 31, leaving few fresh company-specific catalysts for the stock in Monday’s trade. Linde

In that quarterly update, Linde forecast fourth-quarter adjusted earnings per share — a profit measure that strips out some one-off items — of $4.10 to $4.20, citing weaker volumes in Europe. It reaffirmed a full-year outlook for 5% to 6% growth in adjusted EPS, Reuters reported. Reuters

Investors are now focused on whether European volumes stabilize and how pricing and new project wins feed into 2026 guidance when Linde reports next.

Nasdaq’s earnings calendar estimates Linde will report again on Feb. 5. Nasdaq

Stock Market Today

  • Is Pediatrix Medical Group (MD) Undervalued After Nearly 58% One-Year Gain?
    January 18, 2026, 7:04 PM EST. Pediatrix Medical Group's stock surged 57.9% over the past year, trading recently near $21.86. Despite this strong run, a discounted cash flow model estimates an intrinsic value of about $37.38 per share, implying the stock could be 41.5% undervalued. The model uses projected free cash flows extending to 2035, analyzing forecasted cash flow growth. Simply Wall St's valuation framework scores Pediatrix 5 out of 6 for undervaluation potential. Investors reassessing specialized healthcare providers amid this rally may find value opportunities as the share price reflects improved sentiment but remains below longer-term intrinsic value estimates.
Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award
Previous Story

Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award

Warby Parker slides as year-end tech pullback cools the “Santa Claus” trade
Next Story

Warby Parker slides as year-end tech pullback cools the “Santa Claus” trade

Go toTop